Several studies revealed that MAPKAPK2 facilitated progression of diverse cancers by promoting the proliferation (6, 7), evasion (8), apoptosis induction (9), angiogenesis (10), or chemotherapy/radiotherapy resistance (11–13). Here, MAPKAPK2 is linked to cancer.